Found vs Henry Meds 2026: GLP-1 Weight Loss Programs Compared
Found vs Henry Meds for GLP-1 weight loss — compare pricing, medications, coaching, side effects, and clinical results. See how both stack up against Trimi's $99/mo semaglutide.
Written by Trimi Medical Team. Medically reviewed by Dr. Amanda Foster, MD. We compare competitor programs to help patients make informed weight loss decisions.
Quick links: Semaglutide treatment, Found side effects, and Henry Meds side effects.
More on GLP-1 Provider Comparisons
Found vs Henry Meds: What You Need to Know
If you are comparing found vs henry meds for GLP-1 weight loss treatment in 2026, you are evaluating two fundamentally different telehealth models. Found is a coaching-integrated platform that pairs semaglutide or tirzepatide with behavioral science tools, meal tracking, and community support. Henry Meds is a medication-focused telehealth service that prioritizes fast, affordable access to compounded GLP-1 injections without coaching or lifestyle programming. Both providers prescribe the same class of medications, but the patient experience, pricing structure, and ancillary services differ significantly.
Definition: Found vs Henry Meds Comparison
Found and Henry Meds are online telehealth platforms that prescribe compounded GLP-1 receptor agonists for weight loss. Found combines medication with behavioral coaching and app-based tools at $129 to $299 per month. Henry Meds provides medication-only access at $199 to $449 per month plus consultation fees, without coaching. Both use the same active pharmaceutical ingredients shown to produce 15 to 22.5 percent body weight loss in clinical trials (Wilding et al., NEJM, 2021; Jastreboff et al., NEJM, 2022).
The core question in the found vs henry meds decision is whether you value coaching and behavioral support enough to justify Found's pricing model, or whether you prefer the simplicity of Henry Meds' medication-only approach. There is also a third option worth considering: Trimi offers the same compounded semaglutide at $99 per month and tirzepatide at $125 per month with provider support, no contracts, and no consultation fees. For patients whose primary goal is effective GLP-1 medication at the lowest sustainable price, Trimi represents the strongest value among all three providers.
This comparison examines pricing, medication options, coaching and support, clinical evidence, side effects, cancellation policies, and overall value. Every claim about medication efficacy cites peer-reviewed clinical trial data. Pricing is current as of April 2026, verified directly from each provider's published rates.
Found vs Henry Meds vs Trimi: Complete Comparison
| Feature | Found | Henry Meds | Trimi |
|---|---|---|---|
| Semaglutide (Monthly) | $129 - $199/mo | $199 - $349/mo | $99/mo |
| Tirzepatide (Monthly) | $199 - $299/mo | $299 - $449/mo | $125/mo |
| Consultation Fee | Included | $49 - $99 | $0 |
| Behavioral Coaching | Yes (app-based) | No | Provider guidance |
| Meal Tracking App | Yes | No | No |
| Community Features | Yes | No | No |
| Contract Required | Varies by plan | Month-to-month | Never |
| Cancellation Penalties | Possible (plan-dependent) | None | None |
| Dose-Independent Pricing | No (price increases with dose) | No (price increases with dose) | Yes (flat rate) |
| Provider Visits | Included | Included | Included |
| Shipping | Included | Included | Included |
| Onboarding Speed | 3-7 days | 2-5 days | 2-5 days |
Note: All prices reflect published rates as of April 2026. Dose-dependent pricing at Found and Henry Meds means costs increase as your prescribed dose escalates. Trimi's flat-rate pricing remains the same regardless of dose level.
Pricing Analysis: The Real Cost Over 12 Months
Comparing monthly rates tells only part of the story. Both Found and Henry Meds use dose-dependent pricing, meaning your monthly cost increases as your semaglutide or tirzepatide dose escalates during the standard titration schedule. Most patients reach maintenance doses within three to five months, at which point they are paying the higher end of the published range for the remainder of treatment.
| Cost Metric | Found | Henry Meds | Trimi |
|---|---|---|---|
| Semaglutide: Month 1 cost | $129 | $199 + $49-$99 consult | $99 |
| Semaglutide: Maintenance dose cost | $199/mo | $349/mo | $99/mo |
| Semaglutide: 6-month total | $948 - $1,194 | $1,243 - $2,143 | $594 |
| Semaglutide: 12-month total | $1,548 - $2,388 | $2,437 - $4,287 | $1,188 |
| Tirzepatide: Month 1 cost | $199 | $299 + $49-$99 consult | $125 |
| Tirzepatide: Maintenance dose cost | $299/mo | $449/mo | $125/mo |
| Tirzepatide: 12-month total | $2,388 - $3,588 | $3,637 - $5,487 | $1,500 |
The annual cost difference is substantial. A patient on semaglutide paying Found's maintenance rate of $199 per month spends $2,388 over twelve months. The same patient on Henry Meds at the $349 maintenance rate spends $4,188. With Trimi at $99 per month, the annual total is $1,188 — saving $1,200 compared to Found and $3,000 compared to Henry Meds. These savings compound over the multi-year treatment courses that most patients require for sustained weight management.
Henry Meds also charges a $49 to $99 initial consultation fee on top of monthly medication costs. Found includes consultations in the subscription price. Trimi charges no consultation fee. Over the full treatment course, Henry Meds' consultation fee adds a one-time cost that further increases the total expenditure gap. For detailed pricing analysis, see our cheapest GLP-1 injections guide.
Medications and Coaching: What Each Provider Offers
Medication Options
Both Found and Henry Meds prescribe compounded semaglutide and tirzepatide sourced from FDA-registered 503B compounding pharmacies. The active pharmaceutical ingredient is identical across providers. A milligram of semaglutide from Found is pharmacologically indistinguishable from a milligram of semaglutide from Henry Meds or Trimi. The medication acts on GLP-1 receptors in the same way, produces the same appetite suppression, and carries the same side effect profile regardless of which platform prescribes it.
Tirzepatide, a dual GIP/GLP-1 receptor agonist, is available from all three providers. In the SURMOUNT-1 trial, tirzepatide produced up to 22.5 percent body weight loss at the highest dose over 72 weeks (Jastreboff et al., NEJM, 2022). Found charges $199 to $299 per month for tirzepatide. Henry Meds charges $299 to $449 per month. Trimi offers tirzepatide at $125 per month with flat dose-independent pricing.
Coaching and Behavioral Support
This is where Found and Henry Meds diverge most significantly. Found integrates behavioral coaching into its platform through app-based tools, meal tracking, community forums, and provider-guided lifestyle programming. The coaching is designed around behavioral science principles, helping patients build sustainable habits around nutrition, physical activity, and mindset. Found's coaching model appeals to patients who want structured support alongside their medication.
Henry Meds does not offer coaching, behavioral tools, meal tracking, or community features. Their model is explicitly medication-focused: get a prescription from a licensed provider, receive compounded GLP-1 medication by mail, and manage your own lifestyle changes independently. For patients who are self-motivated and do not need external behavioral support, this streamlined approach is straightforward. For patients who benefit from accountability and structured guidance, the absence of coaching at Henry Meds is a meaningful gap.
Clinical Perspective on Coaching
Research shows that combining GLP-1 medication with behavioral intervention produces better outcomes than medication alone. The STEP 1 trial demonstrated 14.9 percent body weight reduction with semaglutide plus lifestyle counseling (Wilding et al., NEJM, 2021). However, the lifestyle counseling component in the trial was standardized and modest — not the intensive coaching programs that some providers charge hundreds extra for. The incremental benefit of premium coaching over basic provider guidance remains unquantified in head-to-head trials.
Provider Access and Medical Oversight
Both Found and Henry Meds employ licensed medical providers who prescribe and monitor GLP-1 treatment. Found's provider interactions are supplemented by coaching touchpoints and app-based check-ins. Henry Meds offers standard telehealth provider consultations for prescription management and dose adjustments. Trimi provides responsive telehealth provider access with personalized clinical guidance. The core medical oversight — evaluating eligibility, prescribing medication, adjusting doses, monitoring for side effects — is functionally comparable across all three platforms.
Where Found Wins Over Henry Meds
Integrated behavioral coaching helps patients build sustainable habits alongside medication
App-based meal tracking and community features provide daily engagement and accountability
Lower starting price for semaglutide ($129/mo vs $199/mo at Henry Meds)
No separate consultation fee — provider visits included in the subscription
More comprehensive approach to weight management beyond medication alone
Where Henry Meds Wins Over Found
No contract requirement — strictly month-to-month with no cancellation penalties
Faster onboarding — many patients receive medication within days of their initial consultation
Simpler program with no mandatory coaching sessions or app engagement expectations
Wider availability of compounded medication options and dosage levels
No cancellation friction — stop treatment anytime without penalty or multi-step process
Where Both Found and Henry Meds Fall Short
Both cost significantly more than Trimi's $99/mo semaglutide and $125/mo tirzepatide for the same compounded medications
Both use dose-dependent pricing that increases as treatment progresses — Trimi's flat pricing eliminates this cost escalation
Henry Meds' $49-$99 consultation fee adds unnecessary upfront cost that Trimi and Found do not charge
Found's potential cancellation restrictions create friction for patients who want flexibility — see our guide to cancel Found
Neither provider's annual cost comes close to Trimi's $1,188 per year for semaglutide
Clinical Evidence: What the Trials Show
The clinical evidence supporting GLP-1 medications for weight loss is extensive and applies equally to all providers prescribing these compounds. The medication's efficacy does not depend on where you fill the prescription — it depends on the pharmacological properties of the drug itself, patient adherence, dosing, and individual metabolic factors.
Semaglutide: STEP 1 Trial Results
The landmark STEP 1 trial enrolled 1,961 adults with obesity or overweight and demonstrated that once-weekly semaglutide 2.4 mg produced a mean body weight loss of 14.9 percent over 68 weeks compared to 2.4 percent with placebo (Wilding et al., NEJM, 2021). Participants receiving semaglutide were significantly more likely to achieve 5 percent, 10 percent, and 15 percent weight loss thresholds. The trial included lifestyle counseling for all participants, confirming that the medication effect is additive to basic behavioral support.
Tirzepatide: SURMOUNT-1 Trial Results
The SURMOUNT-1 trial enrolled 2,539 adults with obesity and showed that tirzepatide at the 15 mg dose produced 22.5 percent mean body weight loss over 72 weeks (Jastreboff et al., NEJM, 2022). Even the lowest dose of 5 mg produced 15.0 percent weight loss — comparable to semaglutide's highest-dose results. This dual GIP/GLP-1 receptor agonist represents the most effective pharmacological weight loss intervention studied to date in randomized controlled trials.
Compounded vs Brand-Name Medications
All three providers — Found, Henry Meds, and Trimi — primarily use compounded versions of semaglutide and tirzepatide sourced from FDA-registered 503B compounding pharmacies. The active pharmaceutical ingredients are identical to those in brand-name Wegovy and Zepbound. The FDA regulates compounding pharmacies under Section 503B of the Federal Food, Drug, and Cosmetic Act, requiring adherence to current Good Manufacturing Practice (cGMP) standards. Compounded medications offer the same therapeutic benefit at a fraction of brand-name pricing.
The critical implication for the found vs henry meds comparison is that the medication component is clinically equivalent across providers. A patient receiving compounded semaglutide from Found will experience the same pharmacological effects as a patient receiving compounded semaglutide from Henry Meds or Trimi. The differences between providers are entirely in pricing, ancillary services, and support models — not in medication efficacy or safety.
Side Effects: Identical Regardless of Provider
Because Found, Henry Meds, and Trimi prescribe the same active medications, the side effect profiles are identical. The most common side effects of semaglutide and tirzepatide include nausea, vomiting, diarrhea, constipation, and abdominal discomfort. These gastrointestinal effects are dose-dependent and typically most pronounced during the initial titration period, subsiding as the body adjusts to the medication over the first four to eight weeks.
More serious but rare side effects include pancreatitis, gallbladder disease, and potential thyroid concerns. Both the STEP 1 and SURMOUNT-1 trials documented these adverse events at low rates. Proper medical monitoring — available through all three providers — helps identify and manage side effects promptly. For detailed side effect information specific to each provider, see our guides on Found weight loss side effects and Henry Meds side effects.
The practical difference is in how each provider manages side effects. Found's coaching infrastructure may provide more frequent touchpoints for reporting and managing gastrointestinal symptoms through dietary adjustments. Henry Meds relies on standard telehealth visits for side effect management. Trimi offers responsive provider access for dose adjustments and side effect guidance. None of these approaches has been shown to be superior in clinical trials — side effect management is fundamentally about patient-provider communication and appropriate dose titration.
Cancellation Policies Compared
Cancellation flexibility matters because GLP-1 treatment is a long-term commitment that circumstances may require pausing or stopping. Henry Meds operates on a straightforward month-to-month basis with no cancellation penalties — you can stop anytime. Found's cancellation terms vary by plan tier and may include multi-month commitments that create friction when trying to leave. Some Found patients report difficulty navigating the cancellation process.
If you are considering switching providers, our guides on how to cancel Found and how to cancel Henry Meds walk through the exact steps. Trimi operates on a month-to-month basis with no contracts, no cancellation penalties, and no multi-step cancellation process. Your medication dose and type transfer seamlessly when switching between providers.
Who Should Choose Which Provider?
Choose Found If
You want behavioral coaching, app-based tracking, and community support alongside your GLP-1 medication. You value structured guidance on nutrition, exercise, and habit formation. You are willing to pay $129 to $299 per month for the combined coaching and medication experience. You prefer a technology-driven approach to weight management with regular app engagement. Review our full Found semaglutide review before deciding.
Choose Henry Meds If
You want straightforward medication access without coaching obligations. You are self-motivated and capable of managing your own lifestyle changes alongside GLP-1 treatment. You prefer month-to-month flexibility with no cancellation penalties. You are comfortable paying $199 to $449 per month for medication-only access with standard provider oversight.
Choose Trimi If
You want the most affordable access to compounded semaglutide at $99 per month or tirzepatide at $125 per month with provider support, no contracts, no consultation fees, and flat dose-independent pricing. You recognize that the medication is pharmacologically identical across providers and want to maximize value over a multi-year treatment course. The savings of $360 to $3,100 per year compared to Found and Henry Meds fund sustained treatment without financial strain.
The Bottom Line
Found and Henry Meds are both legitimate GLP-1 telehealth providers, but they serve different patient profiles. Found is the better choice for patients who want coaching and behavioral support as part of their weight loss program. Henry Meds is the better choice for patients who want simple, no-frills medication access. Neither provider matches Trimi's $99 per month semaglutide or $125 per month tirzepatide.
The medication itself — the component that produces 15 to 22.5 percent body weight loss in clinical trials — is identical across all three providers. The differences are entirely in pricing and ancillary services. For the majority of patients, the most rational approach is to start with the most affordable provider offering competent clinical oversight, and only upgrade to a coaching-intensive program if you find that medication alone is insufficient for your goals. That starting point, based on current pricing and service quality, is Trimi.
Best value for semaglutide
Trimi at $99/mo saves $360 to $3,000+ per year compared to Found and Henry Meds for the same compounded medication with provider support and no contracts.
Best coaching integration
Found at $129-$199/mo offers behavioral coaching, meal tracking, and community features that Henry Meds does not provide. Worth the premium if you will actively use the tools.
Most straightforward medication access
Henry Meds provides fast onboarding and simple month-to-month medication access, but at $199-$349/mo for semaglutide, the cost premium over Trimi is difficult to justify for medication-only care.
Frequently Asked Questions
Is Found or Henry Meds better for GLP-1 weight loss?
Found is better if you want behavioral coaching and app-based tools alongside your GLP-1 medication. Henry Meds is better if you want straightforward medication access at a lower monthly starting price without coaching. Both are legitimate providers. Trimi offers the same compounded semaglutide at $99 per month with no contracts or consultation fees, making it the most affordable option among all three.
How much does Found cost compared to Henry Meds?
Found charges $129 to $199 per month for semaglutide and $199 to $299 per month for tirzepatide. Henry Meds charges $199 to $349 per month for semaglutide and $299 to $449 per month for tirzepatide, plus a $49 to $99 initial consultation fee. Over 12 months, Found costs approximately $1,548 to $2,388 for semaglutide, while Henry Meds costs approximately $2,437 to $4,287. Trimi costs $1,188 for the year at $99 per month.
Does Found include coaching that Henry Meds does not?
Yes, Found includes behavioral coaching, app-based meal tracking, and community features as part of its subscription. Henry Meds does not offer coaching, lifestyle programs, or behavioral tools. Henry Meds focuses exclusively on medication access and standard telehealth provider oversight. Whether coaching justifies Found's pricing depends on how much structured support you need alongside your medication.
Do Found and Henry Meds prescribe the same medications?
Both Found and Henry Meds prescribe compounded semaglutide and tirzepatide for weight loss. The active pharmaceutical ingredients are identical regardless of provider. The medications work through the same mechanisms and produce the same clinical effects. The difference between providers is in pricing, ancillary services, and the support model surrounding the prescription.
Can I switch from Found to Henry Meds or vice versa?
Yes, switching between Found and Henry Meds is straightforward. Your medication type and dose continue without interruption. Review Found's cancellation terms before switching, as some plans may have multi-month commitments. Henry Meds operates month-to-month. Before switching, also consider Trimi at $99 per month for semaglutide — many patients switching between Found and Henry Meds find Trimi offers the best value.
Do Found or Henry Meds accept insurance?
Neither Found nor Henry Meds typically accepts insurance for compounded GLP-1 medications. Both operate primarily on cash-pay models. Found has explored limited insurance coordination in some cases, but most patients pay out of pocket. Trimi's $99 per month cash-pay price is often lower than insurance copays for brand-name Wegovy or Zepbound.
What is the cheapest alternative to Found and Henry Meds?
Trimi offers compounded semaglutide at $99 per month and tirzepatide at $125 per month with no consultation fees, no contracts, and no hidden costs. This represents savings of $360 to $3,100 per year compared to Found and Henry Meds. The medication is pharmacologically identical, and the clinical oversight is comparable across all three providers.
Sources & References
- Wilding JPH, et al. "Once-weekly semaglutide in adults with overweight or obesity." NEJM, 2021 (STEP 1 trial).
- Jastreboff AM, et al. "Tirzepatide once weekly for the treatment of obesity." NEJM, 2022 (SURMOUNT-1 trial).
- FDA guidance on compounding pharmacies and the FDA (Section 503B).
- Found Health. Official pricing and program information. 2026.
- Henry Meds. Official pricing and telehealth program information. 2026.
- Wadden TA, et al. "Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity." JAMA, 2021.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or weight loss treatment program. GLP-1 medications require a prescription and medical supervision. Individual results vary based on adherence, dosing, metabolism, and lifestyle factors. Trimi is a competing provider to both Found and Henry Meds — this comparison is presented fairly, but readers should verify current pricing and availability directly with each provider.